Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Assay Antibody is a generic term describing an immunoglobulin used as a reagent in laboratory procedures to detect, quantify, or localize a specific target analyte. These antibodies are essential components of diagnostic and research tools such as Enzyme-Linked Immunosorbent Assays (ELISA), Western blots, and immunohistochemistry (IHC) (Thermo Fisher Scientific, 2024). They function through high-affinity binding to specific epitopes on a target molecule, often coupled with a detection system like a fluorophore or enzyme to provide a measurable signal (NCBI, 2023). In a typical assay, a primary antibody binds the target, while a secondary antibody may be used to amplify the signal for better sensitivity. Because Assay Antibody refers to a functional category of laboratory tools rather than a specific biological protein or pathway, it is not considered a therapeutic target for drug development. Its primary role is in the measurement of biomarkers and the monitoring of therapeutic responses rather than as a mediator of disease or a site of pharmacological action. Consequently, it does not possess a therapeutic mechanism of action or associated interacting drugs.
Not applicable
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Assay Antibody.